Regenstrief Research Scientist Shelley Johns, PysD, outlined how acceptance and commitment therapy can be beneficial to breast cancer survivors who are dealing with fear of cancer recurrence.
-
Research
- Experts
In The News
View All
AP News features LOINC
LOINC, developed and maintained by the Regenstrief Institute, was featured by AP...
Influence
View All
Primary Care and Survival: Implications for Research and Policy
Published in the Journal of General Internal Medicine. Here is a link...
- About
- The Latest
- Collaboration
Generating Evidence Across the Full Arc of Disease
Regenstrief Institute x Merck The Question Clinical trials establish whether...
Evaluating AI-Enabled Trial Screening in Real-World Oncology Workflows
Regenstrief, Triomics and Indiana University Health, supported by an independent...
- Experts